| abstract |
The present invention provides anti-oncostatin M receptor-beta (OSMR) antigen binding proteins, such as antibodies and functional fragments, derivatives, muteins and variants thereof. OSMR antigen binding proteins interfere with the binding of OSM and/or IL-31 to OSMR. In some embodiments, anti-OSMR antigen binding proteins are useful tools in the study of diseases and disorders associated with OSMR and in methods of treating diseases and disorders associated with OSMR and the binding of OSM and/or IL-31 to OSMR Especially useful. |